https://www.selleckchem.com/pr....oducts/hsp27-inhibit
Our results provide a proof of concept of the utility of these assays in clinical trials targeting the hIL-33/hST2 pathway. Unlike existing commercial hIL-33 assays, our hIL-33 bioassays are highly sensitive and specific and can accurately quantify hIL-33 in various human clinical matrices, including those with high levels of hsST2. Our results provide a proof of concept of the utility of these assays in clinical trials targeting the hIL-33/hST2 pathway.Bullous pemphigoid (BP) is the most common autoimmune bullous skin diseas
Like
Comment
Share
